Jacqueline French, MD

Genetic testing is rapidly changing the evaluation of epilepsy, with some of its greatest diagnostic yield seen among children with seizures and developmental delay.

Moving from pediatric to adult epilepsy care can disrupt years of accumulated clinical knowledge, and Jacqueline French, MD, outlines how stronger handoffs and longitudinal records can help preserve continuity.

Beyond seizure control, Jacqueline French, MD, examines how clinicians can more proactively uncover psychiatric, cognitive, behavioral, sleep, and other comorbidities that shape the lives of patients with epilepsy.

In this episode, neurologist Jacqueline French, MD, outlines a practical approach to suspected epilepsy, including how clinical history, EEG, MRI, cell phone video, and prolonged monitoring can help establish and refine the diagnosis.

In this initial segment, epileptologist Jacqueline French, MD, discusses the often-overlooked burdens of epilepsy, including the anxiety of unpredictable seizures, mortality risk, and the demands of maintaining consistent treatment. For people with epilepsy, disease burden cannot be fully captured by counting seizures. The possibility that a seizure could occur without warning can affect how patients approach work, relationships, independence, and everyday activities, creating a persistent psychological burden even during periods when seizures are relatively infrequent.

The director of Translational Research and Clinical Trials Epilepsy at NYU Grossman School of Medicine discussed the need to improve education about nonmotor seizures.

The director of Translational Research and Clinical Trials Epilepsy at NYU Grossman School of Medicine discussed the groundwork done with the Human Epilepsy Project for a recent analysis.

The professor of neurology at NYU Langone Medical Center discussed the importance of these safety data for intranasal diazepam, and why future comparative data would be essential.

The director of Translational Research and Epilepsy Clinical Trials at NYU Langone spoke about the nuance involved in diagnosing epilepsy and the misconceptions about how seizures present in the majority of patients.

The professor of neurology and director of translational research and epilepsy clinical trials at NYU Langone spoke about the results of a phase 2b open-label feasibility study of this novel delivery method for abortive seizure treatment in patients with epilepsy.